ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC72.2

C72.2

Billable

Malignant neoplasm of olfactory nerve

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C72.2 is a billable code used to indicate a diagnosis of malignant neoplasm of olfactory nerve.

Key Diagnostic Point:

Malignant neoplasm of the olfactory nerve is a rare and aggressive tumor that arises from the olfactory nerve, which is responsible for the sense of smell. These tumors can be classified as primary or secondary, with primary tumors originating from the olfactory nerve itself and secondary tumors resulting from metastasis from other malignancies. Clinically, patients may present with symptoms such as anosmia (loss of smell), nasal obstruction, and neurological deficits due to the tumor's proximity to critical structures in the central nervous system (CNS). Imaging studies, particularly MRI, are essential for diagnosis and treatment planning, as they provide detailed visualization of the tumor's size, location, and involvement of surrounding tissues. Molecular markers, such as IDH1 mutations and 1p/19q co-deletion status, may also play a role in the prognosis and treatment response. Given the tumor's location, surgical intervention is often necessary, and the prognosis can vary significantly based on the tumor's histological characteristics and the extent of resection achieved.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Rarity of the condition leading to limited coding experience
  • Need for precise documentation of tumor type and location
  • Potential for overlapping symptoms with other CNS tumors
  • Complexity of imaging and diagnostic criteria

Audit Risk Factors

  • Inadequate documentation of tumor type and characteristics
  • Failure to specify the laterality of the tumor
  • Misclassification of benign versus malignant neoplasms
  • Inconsistent use of imaging studies in documentation

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans must be documented.

Common Clinical Scenarios

Diagnosis and management of olfactory nerve tumors, including surgical interventions and chemotherapy.

Billing Considerations

Ensure accurate staging and grading of the tumor to reflect treatment decisions.

Neurology

Documentation Requirements

Neurological assessments, imaging results, and symptomatology must be clearly documented.

Common Clinical Scenarios

Evaluation of patients with neurological deficits related to olfactory nerve tumors.

Billing Considerations

Document any cognitive or sensory deficits that may arise from the tumor's impact on CNS function.

Coding Guidelines

Inclusion Criteria

Use C72.2 When
  • Follow the official ICD
  • CM coding guidelines, ensuring that the diagnosis is supported by clinical documentation
  • Include any relevant imaging studies and pathology reports to substantiate the diagnosis

Exclusion Criteria

Do NOT use C72.2 When
  • Exclude conditions that do not meet the criteria for malignant neoplasms

Related ICD-10 Codes

Related CPT Codes

61510CPT Code

Craniotomy for excision of tumor

Clinical Scenario

Used during surgical intervention for C72.2.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Neurosurgery must document the extent of resection and any complications.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of CNS malignancies, including C72.2, which enhances the ability to track and analyze these rare tumors. This specificity aids in research and treatment planning.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of CNS malignancies, including C72.2, which enhances the ability to track and analyze these rare tumors. This specificity aids in research and treatment planning.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of CNS malignancies, including C72.2, which enhances the ability to track and analyze these rare tumors. This specificity aids in research and treatment planning.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What imaging is required for diagnosing C72.2?

MRI is the preferred imaging modality for diagnosing malignant neoplasms of the olfactory nerve, providing detailed images of the tumor's size and location.